Repaglinide

NDC 33342-250 · Macleods Pharmaceuticals Limited

Generic nameRepaglinide

Dosage formTABLET

RouteORAL

Active ingredient(s)REPAGLINIDE

Strength2 mg/1

Pharmacologic classGlinide [EPC], Potassium Channel Antagonists [MoA]

Marketing categoryANDA

Packages

33342-250-11 — 100 TABLET in 1 BOTTLE (33342-250-11)

33342-250-44 — 1000 TABLET in 1 BOTTLE (33342-250-44)

FDA lists these products with the same active ingredient.

33342-248 — Repaglinide, 33342-249 — Repaglinide, 57237-157 — Repaglinide, 57237-158 — Repaglinide, 57237-159 — Repaglinide, 60687-560 — Repaglinide, 62135-946 — Repaglinide, 62135-947 — Repaglinide, 62135-948 — Repaglinide, 63629-4866 — Repaglinide, 65862-670 — Repaglinide, 65862-671 — Repaglinide, 65862-672 — Repaglinide, 71335-2554 — Repaglinide, 71335-2598 — Repaglinide, 72162-2558 — Repaglinide, 72603-810 — Repaglinide, 72603-811 — Repaglinide, 72603-812 — Repaglinide

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.